HPV Cancer Risks: PICOT Analysis

Cite this

Introduction

For several years, medical researchers have tried to find a solution for curing cancer. Currently, many people across the globe are experiencing a different kind of cancer. Despite their efforts to seek medical attention, the majority of the patients have succumbed to the disease. It is an illness that does not spare any individual regardless of age, gender, and even social status. As a result, there are attempts to educate the parents of children of ages 11 and 12 to curb cancer disease occurrence. Although there have been campaigns to enlighten people about HPV cancer risks, most parents are still reluctant to encourage their kids to get three-dose vaccination.

Cut 15% OFF your first order
We’ll deliver a custom Oncology paper tailored to your requirements with a good discount
Use discount
322 specialists online

Problem Statement

With modern technology and the numerous studies conducted to prevent cancer, many people are still reluctant to get the vaccination. According to Garrido et al. (2016), most patients still die of the disease even after completing their treatment sessions. However, “HPV vaccine” (2020) illustrates that most cancer diseases are caused by Human Papillomavirus (HPV). Despite the evidence, teenagers are often reluctant to get vaccinated to contain the condition due to inconsistent information. Garrido (2016) illustrates that parents are to be blamed for the low vaccination rates experienced across the US. Therefore, there is a need to determine if educating the parents of children aged 11 and 12 impacts teenagers getting the three-dose vaccine.

PICOT Research Question

In teenagers ages of 11 and 12 years old, does educating parents about HPV cancer risks, compared with no education, increase the numbers of teenagers getting the three-dose vaccine, in a 5-month time?

The population of Interest (Teenagers Ages of 11 and 12 Years Old)

The three-dose vaccine is usually given to 15 years old and above to prevent cancer from occurring. According to CDC (n.d.), it is recommended for cancer vaccines to be started at the ages of 11 and 12 years. At this age, parents still have complete control over their children. Vaccinating a child at an early age inhibits the HPV virus; hence, the kids are free from exposure to cancer.

The Intervention of Interest (Educating Parents about HPV Cancer Risks)

Prevention is the primary intervention technique of cancer treatments across the globe. According to Fayanju et al. (2019), prevention can only be achieved if the general public is aware of the cancer risks. However, little is known about HPV risks which cause several cancer diseases. According to Garrido (2016), if the public is educated and made aware of the HPV cancer risks, people will seek measures to prevent the disease. Across the US, many parents are not familiar with the HPV virus, and they only believe that cancer is caused by the lifestyle that people adopt. Therefore, the only effective way to mobilize people to vaccinate is through educating the parents.

Comparison of Interest (Compared with no Education)

Lack of parental education on HPV cancer risks decreases the number of teenagers getting the three-dose vaccine. According to witness expert Dr. Young, in his submission to the International Tribunal for Natural Justice (2019), he illustrates that it is healthy for people not to know cancer causes. Additionally, the expert explains that the vaccines create courage but do little in preventing cancer (ITNJ, 2019). In fact, the jabs are meant to enrich pharmaceutical companies that reap huge profits from the exercise. Moreover, teenagers are usually rebellious and, in some cases, they do not listen to their parents; thus, they can refuse to take the vaccines even though their parents are educated.

The Outcome of Interest (Increase the Numbers of Teenagers Getting the Three-Dose Vaccine)

The expected outcome is to determine the number of teenagers getting the three-dose vaccine. There is currently a need to prevent cancer, which can be achieved if effective vaccines are given to the patients. However, vaccines are usually effective if administered before the disease-causing organism becomes active in the body. Therefore, it is recommended for people to get vaccinated at an early age. However, parents’ actions can determine if a child receives the jab or not. For instance, if the parents are educated and aware of the benefits of getting the vaccine, their children will be vaccinated when they reach the recommended age. Therefore, the number of teenagers getting the three-dose vaccine is expected to increase if their parent is educated.

On-Time Delivery!
Get your customized and 100% plagiarism-free paper done in as little as 3 hours
Let’s start
322 specialists online

Time Frame (in a 5 Month Time)

Although children aged 11 and 12 are given the two-dose vaccine, teenagers aged 15 and above are expected to get three-dose vaccines. The subsequent jabs should be given five months from when the initial vaccine was administered since teenagers might be exposed to the HPV because they are usually sexually active. The research project will take five months due to the nature of the information that is required. The time will be enough to review all the necessary studies that have been conducted and also interview the stakeholders.

Conclusion

In conclusion, parents play a crucial role in ensuring that their teenage children get the three-dose vaccine. If the parents are aware of the benefits of getting the jab, they will take their kids vaccinations in the healthcare facility. Moreover, they will advise their teenage children to seek vaccination since most kids usually implement what their parents say even though some can be rebellious. Therefore, it is crucial to determine the evidence showing that the treatment techniques contribute to the recovery process.

References

CDC. (n.d.). HPV vaccine recommendations.

Fayanju, O. M., Yenokyan, K., Ren, Y., Goldstein, B. A., Stashko, I., Power, S., Thornton, M. J., Marcom, K. & Hwang, E. S. (2019). The effect of treatment on patient‐reported distress after breast cancer diagnosis. Cancer, 125(17), 3040−3049.

Garrido, F., Aptsiauri, N., Doorduijn, E. M., Lora, A. M. G., & van Hall, T. (2016). The urgent need to recover MHC class I in cancers for effective immunotherapy. Current Opinion in Immunology, 39, 44−51.

Get a custom-written paper
For only $13.00 $11/page you can get a custom-written academic paper according to your instructions
Let us help you
322 specialists online

HPV vaccine: Who needs it, how it works. (2020). Mayo Clinic.

International Tribunal for Natural Justice. (2019). Dr. Robert O. Young ITNJ testimony [Video]. YouTtube. Web.

Cite this paper

Select style

Reference

NursingBird. (2022, July 22). HPV Cancer Risks: PICOT Analysis. Retrieved from https://nursingbird.com/hpv-cancer-risks-picot-analysis/

Reference

NursingBird. (2022, July 22). HPV Cancer Risks: PICOT Analysis. https://nursingbird.com/hpv-cancer-risks-picot-analysis/

Work Cited

"HPV Cancer Risks: PICOT Analysis." NursingBird, 22 July 2022, nursingbird.com/hpv-cancer-risks-picot-analysis/.

References

NursingBird. (2022) 'HPV Cancer Risks: PICOT Analysis'. 22 July.

References

NursingBird. 2022. "HPV Cancer Risks: PICOT Analysis." July 22, 2022. https://nursingbird.com/hpv-cancer-risks-picot-analysis/.

1. NursingBird. "HPV Cancer Risks: PICOT Analysis." July 22, 2022. https://nursingbird.com/hpv-cancer-risks-picot-analysis/.


Bibliography


NursingBird. "HPV Cancer Risks: PICOT Analysis." July 22, 2022. https://nursingbird.com/hpv-cancer-risks-picot-analysis/.